South America News

Found 1,596 articles

• Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2023

  3/17/2023

  Pharma-Bio Serv, Inc. announced that revenues for the quarter ended January 31, 2023 were approximately $4.2 million, a net decrease of approximately $0.8 million when compared to the same period last year.

• EDAN Launches New Location in Peru to Bolster Its Latin Americas Footprint

  3/13/2023

  Edan Instruments, Inc., a healthcare company and medical device manufacturer, celebrated the Grand Opening of their newly established Peru office, Edan Diagnostics Peru S.A.C., in Lima, with a ribbon cutting ceremony last Friday.

• Pharma-Bio Serv Announces Special Dividend - March 01, 2023

  3/1/2023

  Pharma-Bio Serv, Inc., a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, medical device, cosmetic, food and allied products industries, announced that the Board of Directors approved a Special Dividend of $0.075 per share for shareholders.

• Genomma Lab Internacional Reports Fourth Quarter & Full Year 2022 Results

  2/22/2023

  Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma Lab" or "the Company"), today announced its results for the fourth quarter and full year ended December 31, 2022.

• Procaps Issues Shareholder Letter and Provides Preliminary Fiscal Year 2022 Financial Results and 2023 Guidance

  2/13/2023

  Procaps Group, a leading integrated LatAm healthcare and pharmaceutical conglomerate, issued a letter to shareholders from Ruben Minski, Chairman of the Board and CEO of Procaps, including preliminary select financial results for the fiscal year ended December 31, 2022 and guidance on its near term growth prospects.

• Pharma-Bio Serv Retains Investment Banking Firm ACP Capital to Provide Investment Banking and M&A Advisory Services

  2/7/2023

  Pharma-Bio Serv, Inc. announced that it has retained ACP Capital Markets LLC for investment banking and M&A advisory services.

• Pharma-Bio Serv Announces Full Year Results

  1/30/2023

  Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), is a regulatory, compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, medical device, cosmetic, food and allied products industries.

• Dr. Rohit Varma Shares Eye-Disease Research at the 2nd Mexico-United States Symposium on Vision Health

  1/27/2023

  More than 40 leading ophthalmologists, vision researchers, and public health/policy experts are sharing data and holding discussions on the global burden of diabetes-related eye disease to develop a plan to address this leading cause of blindness at the 2nd Mexico-U.S. Symposium on Vision Health.

• Procaps Announces Key Changes to the Board of Directors

  1/19/2023

  Procaps Group, a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced the election of Alberto Eguiguren Correa to its Board of Directors.

• IFC and Genomma Lab signed a Multi-currency Long-term Loan to Boost Access to OTC Medicines in Latin America and the Caribbean Region

  1/9/2023

  To increase access to high quality and affordable medicines in Latin America and the Caribbean Region and address the impact of the COVID-19 pandemic at a global scale, IFC is providing a US$60 million multi-currency long-term loan to Genomma Lab Internacional, S.A.B. de C.V., a leading pharmaceutical company based in Mexico.

• World Orphan Drug Alliance Announces Agreement with Theratechnologies for the Distribution of EGRIFTA SV

  1/5/2023

  The World Orphan Drug Alliance, a global alliance of commercial distributors focused on providing access to treatments for rare diseases and specialty medicines in complex and underserved markets around the world, announced a long-term, multi-territorial distribution agreement with Theratechnologies Inc. for EGRIFTA SV® in 41 countries.

• Procaps Group Announces Termination of Acquisition Agreement with Grupo Somar

  1/3/2023

  Procaps Group, S.A., a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced the termination of its previously-reported definitive agreement to acquire Grupo Somar from the sellers under the SPA.

• Procaps to Present at 2023 Annual J.P. Morgan Healthcare Conference

  12/29/2022

  Procaps Group, S.A., a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced that it will present at the 2023 J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, at 8:00 am PST.

• Genomma Lab Internacional Announces Leadership Succession Plan

  11/28/2022

  Genomma Lab Internacional, S.A.B. de C.V. announces a leadership succession plan that positions the Company to continue driving profitable growth and delivering on the Company's vision, as CEO Jorge Brake has informed the Board of his intention to transition from the CEO role while maintaining active involvement in the Company's future.

• Procaps Group Reports Third Quarter and Nine Months 2022 Results

  11/14/2022

  Procaps Group S.A., a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced its financial results for the three months ended September 30, 2022 and the nine months ended September 30, 2022.

• Procaps Group to Report Third Quarter and Nine Months of 2022 on November 14, 2022

  11/8/2022

  Procaps Group, a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced that it expects to report its results for the third quarter ended September 30, 2022, after the market closes on Monday, November 14, 2022.

• Genomma Lab Internacional Announces Third Dividend Payment - October 27, 2022

  10/27/2022

  Genomma Lab Internacional, S.A.B. de C.V. informs that the Company filed a Notice of Rights with the Mexican Stock Exchange declaring a cash dividend of $0.381679389 Mexican pesos per share on its common stock representing a total amount of $ 400,000,000.00 M.N., payable to shareholders of record at the close of business on November 11, 2022.

• First U.S. CLIA Lab Implements Alpenglow's 3D Spatial Biology Platform Extending AI-Enabled Pathology to 3D

  10/17/2022

  CorePlus Servicios Clínicos y Patológicos, LLC (CorePlus), a leader in AI-based solutions for cancer detection in pathology, is scaling their expertise in digital pathology to new heights in 3D with Alpenglow Biosciences' full 3D spatial biology offering.

• 

  The Best Way to Answer Salary Interview Questions

  10/13/2022

  Interviews can be difficult in any field, but especially in a competitive industry like the life sciences. Read on to discover the best way to answer salary interview questions in our guide.

• Procaps Announces ESG Commitments and Initiatives with Inaugural Report

  10/11/2022

  Procaps Group, a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced the completion of its inaugural 2021 ESG Annual Report, a comprehensive overview of environmental, social and governance metrics and corresponding strategies and initiatives for ESG priorities.